Axovant Sciences (Nasdaq: AXON) ("Axovant") today announced that it has commenced an underwritten public offering of its common shares. All ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Axovant Sciences (AXON) Prices 30M Share Offering at $1/ShDecember 14, 2018 9:02 AM Axovant Sciences Announces Public Offering of Common SharesDecember 13, 2018 4:56 PM Axovant Sciences (AXON) Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from UMassDecember 13, 2018 4:39 PM Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical SchoolDecember 13, 2018 4:01 PM